Request Demo
Last update 13 Dec 2025
GR-2002
Last update 13 Dec 2025
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms GR 2002, GR2002 |
Target |
Action inhibitors |
Mechanism TSLP inhibitors(Thymic stromal lymphopoietin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with GR-2002NCT06175143
A Randomized, Double-Blind, Placebo-Controlled, Phase Ib Clinical Trial to Evaluate the Tolerability, Safety, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of GR2002 Injection in Patients With Moderate to Severe Atopic Dermatitis
NCT05954611
A Phase I, Randomized, Blinding, Single-dose, Placebo Control Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effect of GR2002 in Chinese Health Volunteers
100 Clinical Results associated with GR-2002
Login to view more data
100 Translational Medicine associated with GR-2002
Login to view more data
100 Patents (Medical) associated with GR-2002
Login to view more data
1
Literatures (Medical) associated with GR-200201 Jul 2025ALLERGY
Preclinical Development of GR2002 , a Novel Anti‐TSLP Bispecific Antibody With Potent TSLP Inhibitory Effects
Letter
Author: Luo, Suya ; Hao, Xiaobo ; Zhang, Xueping ; Liu, Yulan ; Liu, Zhigang ; Qin, Hongtao ; Hu, Junjie ; Yang, Jiaqian
100 Deals associated with GR-2002
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Moderate Atopic Dermatitis | Phase 1 | China | 08 Dec 2023 | |
| Severe Atopic Dermatitis | Phase 1 | China | 08 Dec 2023 | |
| Asthma | Phase 1 | China | 16 Jun 2023 | |
| Chronic rhinosinusitis with nasal polyps | IND Approval | China | 09 May 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free